Purdue and Elanco Animal Health announce One Health Innovation District in Indianapolis (2024)

Purdue joins Elanco in a shared vision of a research park dedicated to solving pressing issues impacting animal, plant, human and environmental health

INDIANAPOLIS — Purdue University will partner with Elanco Animal Health Inc. and become part of Indiana’s new One Health Innovation District. The announcement was made Thursday (May 23) at Indiana’s 2024 Global Economic Summit after Purdue President Mung Chiang and Elanco President and CEO Jeff Simmons signed a shared memorandum of understanding with the Indiana Economic Development Corp. to establish a globally recognized research innovation district dedicated to optimizing the health of people, animals, plants and the planet.

Purdue and Elanco have committed to develop a new shared-use facility on 3 acres in the One Health Innovation District near the future Elanco global headquarters on the western edge of the White River in Indianapolis. The facility is designed to deliver and scale up innovation where industry and academia can collaborate including office, wet lab and incubator space. This is in addition to the nearly complete 220,000-square-foot corporate headquarters of Elanco Animal Health, with an expected opening date in the second quarter of 2025. Elanco also announced its commitment to purchase an additional 12 acres to the north of its existing footprint for future expansion and the development of the Epicenter for Animal Health.

Purdue and Elanco Animal Health announce One Health Innovation District in Indianapolis (1)Purdue President Mung Chiang, alongside Indiana Gov. Eric Holcomb (right) and Elanco CEO Jeffrey Simmons (center), discusses the new One Health Innovation District during Thurs Download image

“Totality of Purdue to the totality of Indianapolis — that’s our pledge as the Indianapolis part of Purdue’s main campus officially launches on July 1,” Chiang said. “In the coming years, all programs at Purdue will find homes throughout our state’s capital city. Today’s announcement carries a special excitement for the partnership and the location. Purdue is excited to partner with Elanco and other collaborators to build out the ecosystem of One Health Innovation District, starting from the building announced and expanding to an entire district. Human health, animal health, plant health will be jointly advanced by the nation’s leading companies and our state’s top-ranked university.”

The facility will help extend Purdue’s substantial research arm into the heart of Indianapolis, coinciding with the launch of the university’s urban extension, Purdue University in Indianapolis, on July 1. Research interests will include understanding of the microbiome, antimicrobial resistance, computational biology, comparative genomics and livestock sustainability, among others. Indianapolis is home to the biotech companies that are on the cutting edge of the revolution in animal health (Elanco), human health (Eli Lilly and Company) and plant health (Corteva Agriscience). The One Health Innovation District will be less than 1 mile from Lilly’s world headquarters, creating a unique and direct link between the two entities.

“The One Health Innovation District will propel the state’s vision for our regional technology hub aimed at accelerating collaborative innovation in our life sciences,” Indiana Gov. Eric Holcomb said. “The partnership marks a rare and noteworthy move wherein a global health company, a university and a government come together with a shared vision. The district will create an ecosystem that is focused on talent, applied research and innovation that can be sustained for generations to come.”

Developing the One Health Innovation District surrounding the new Elanco global headquarters presents a unique opportunity to enable a coordinated partnership among public, private, government, university and community that will attract and retain top talent and drive growth and development for downtown Indianapolis. One Health is recognized by scientific institutions including the World Health Organization and the Centers for Disease Control and Prevention as being a preferred approach where the interconnection among human, animal and plant science can help solve complex global health problems.

“For life-changing innovations to move from idea to reality, they must grow in the right environment,” Simmons said. “The many partners in the Indianapolis One Health Innovation District will set Indianapolis apart as an area where innovators will find a vast ecosystem of support — including one of the world’s leading universities, funding, lab space, collaboration with many other innovators and companies — and most significantly, shared technical development and pilot plant facilities to manufacture and scale innovations. We believe connecting innovators with access to world-class, state-of-the-art resources will help bring solutions to some of the world’s most pressing issues facing people, animals and the environment. This is a key milestone in bringing to life our goal of creating an animal health epicenter to reach the world’s animals from our new global headquarters in the heart of Indianapolis.”

The unique partnership is designed to increase the ability to prevent, predict, detect and respond to health threats. One Health integrated approaches are widely recognized as the new frontier in biosciences. Purdue and Elanco, in collaboration with Applied Research Institute, AgriNovus, BiomEdit and others, are planning a One Health Summit for fall to showcase the ecosystem of capabilities and draw the first era of innovators to the One Health District.

This new announcement is yet another step forward to bring to fruition Gov. Holcomb’s goal of developing a regional technology hub in Indiana. Following the passage of the CHIPS and Science Act, through the newly constituted Applied Research Institute (ARI), Indiana stood up Heartland BioWorks and was designated as one of 31 Tech Hubs in October of last year by the Economic Development Administration (EDA). Purdue University was part of a consortium of Indiana stakeholders successful in securing that Regional Technology and Innovation Hub (Tech Hub)designation, which recognizes regions poised to ensure the U.S. is globally competitive in areas that are key to national security. The One Health Innovation District is part of that consortium, and any implementation funding from the EDA would support and greatly accelerate the district’s capability to translate innovative ideas into real-world products and job opportunities. With awards expected this summer, Heartland BioWorks now awaits word on whether it will be chosen for the next phase of funding that will invest another $50 million to $75 million in five to 10 designated hubs around the country. This Regional Tech Hub Program was authorized by the CHIPS and Science Act, of which U.S. Sen. Todd Young, R-Ind., was a co-sponsor.

About Purdue University

Purdue University is a public research institution demonstrating excellence at scale. Ranked among top 10 public universities and with two colleges in the top four in the United States, Purdue discovers and disseminates knowledge with a quality and at a scale second to none. More than 105,000 students study at Purdue across modalities and locations, including nearly 50,000 in person on the West Lafayette campus. Committed to affordability and accessibility, Purdue’s main campus has frozen tuition for 13 years in a row. See how Purdue never stops in the persistent pursuit of the next giant leap — including its first comprehensive urban campus in Indianapolis, the new Mitchell E. Daniels, Jr. School of Business, and Purdue Computes — at https://www.purdue.edu/president/strategic-initiatives.

About Elanco

Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose™ Sustainability/ESG Initiatives — all to advance the health of animals, people and the planet. Learn more atwww.elanco.com.

Writer/Media contact:Derek Schultz,dcschultz@purdue.edu

Sources:Mung Chiang, Eric Holcomb, Jeff Simmons

Purdue and Elanco Animal Health announce One Health Innovation District in Indianapolis (2024)

FAQs

Purdue and Elanco Animal Health announce One Health Innovation District in Indianapolis? ›

On May 24 Purdue announced it will partner with Elanco Animal Health Inc. and become part of Indiana's new One Health Innovation District and its focus on establishing a globally recognized research innovation district dedicated to optimizing the health of people, animals, plants and the planet.

What is the Elanco animal health strategy? ›

For our customers, we promise to be your advocate and continually earn your trust, improving the health of animals, and creating value through innovative products, expertise and service. We find ways to add value with every customer engagement, addressing what matters most, and constantly raising the bar.

Is Elanco moving to Indianapolis? ›

We are providing engineering services for Elanco Animal Health Corporate Headquarters in Indianapolis, Indiana. Elanco, the second-largest independent animal health company in the world, is building a new global headquarters in Indianapolis, Indiana.

What is Elanco Animal Health Mission Statement? ›

Elanco Mission Statement

We provide those who raise and care for animals with a comprehensive set of animal health products and knowledge services that empower them to address the global challenges of a diverse and changing world.

How many employees does Elanco Animal Health have? ›

We Are Elanco

At Elanco, we have nearly 10,000 employees across the world.

Who owns Elanco Animal Health? ›

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Greenfield, Indiana, U.S.

Does Lilly still own Elanco? ›

Elanco Completes Separation from Lilly

Elanco becomes a fully-independent pure play animal health company.

Why did Bayer sell to Elanco? ›

A $7 billion pet healthcare acquisition

Elanco pursued the Bayer merger for two key reasons. The first is that historically, Elanco has been focused on supplying the livestock animal healthcare market, but wanted to expand its reach into the faster-growing pet healthcare market.

What was the old name of Elanco? ›

The Elanco brand, short for Eli Lilly and Company, came to be in 1960, following the reorganization of Eli Lilly and Company's Agricultural and Industrial Sales Division.

How big is Elanco Animal Health? ›

Fourth Quarter 2023 Financial Results: Revenue of $1,035 million. Reported Net Loss of $141 million, Adjusted Net Income of $39 million.

Who is the CEO of Elanco? ›

Jeffrey Simmons serves as president and chief executive officer of Elanco Animal Health. A global leader with a nearly 70-year track record of growth, Elanco provides comprehensive products and knowledge services to improve animal health, welfare and food animal production across 19 species in almost 100 countries.

What is the slogan of Elanco? ›

This aligns with Elanco's tagline of "making lives better for animals, makes lives better."

Where is Elanco headquartered? ›

How much does the CEO of Elanco make a year? ›

Management criteria checks 2/4. Elanco Animal Health's CEO is Jeff Simmons, appointed in Jul 2018, has a tenure of 5.92 years. total yearly compensation is $13.66M, comprised of 8.8% salary and 91.2% bonuses, including company stock and options.

What is the net worth of Elanco Animal Health? ›

Elanco Animal Health has a market cap or net worth of $8.92 billion as of June 21, 2024. Its market cap has increased by 79.30% in one year.

Who is the competitor of Elanco? ›

The main competitors of Elanco Animal Health include Alnylam Pharmaceuticals (ALNY), Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Royalty Pharma (RPRX), BioMarin Pharmaceutical (BMRN), Sarepta Therapeutics (SRPT), BeiGene (BGNE), United Therapeutics (UTHR), Viatris (VTRS), and Dr.

What is the Elanco animal welfare policy? ›

We are dedicated to safeguarding the welfare of farm animals, pets, and research animals worldwide. Our approach to animal welfare takes a holistic view of animal care that extends beyond the role of our animal health products and services.

What is the Elanco Fundamentals of animal science certification? ›

The Elanco Fundamentals of Animal Science Certification verifies individuals have acquired the foundational knowledge and skills to pursue a career within the animal science industry.

Is Elanco Animal Health a good stock to buy? ›

Elanco Animal Health has a consensus rating of Moderate Buy which is based on 5 buy ratings, 2 hold ratings and 1 sell ratings.

What does Elanco do for dogs? ›

Our companion animal research and development focuses on innovative, effective products and therapeutic solutions for pets. We develop solutions that treat pain and prevent disease, enhance and extend quality of life, and improve the type of care that pets receive.

Top Articles
Latest Posts
Article information

Author: Jamar Nader

Last Updated:

Views: 5972

Rating: 4.4 / 5 (75 voted)

Reviews: 90% of readers found this page helpful

Author information

Name: Jamar Nader

Birthday: 1995-02-28

Address: Apt. 536 6162 Reichel Greens, Port Zackaryside, CT 22682-9804

Phone: +9958384818317

Job: IT Representative

Hobby: Scrapbooking, Hiking, Hunting, Kite flying, Blacksmithing, Video gaming, Foraging

Introduction: My name is Jamar Nader, I am a fine, shiny, colorful, bright, nice, perfect, curious person who loves writing and wants to share my knowledge and understanding with you.